Novartis Pharma AG

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Novartis Pharma AG
CIK #0001030617
EDGAR Form CIK 2011 - 2025
3 [0001030617]
4 [0001030617]
SC 13D [0001030617]
SC 13G [0001030617]
Form 13D/13G Filer Form 13D/13G Subject Filed
Novartis Pharma AG Erasca Inc [2022-12-19]
Novartis Pharma AG Precision Biosciences Inc [2022-06-27]
Novartis Pharma AG Somalogic Inc [2021-10-08]
Novartis Pharma AG Poseida Therapeutics Inc [2021-02-12]
Novartis Pharma AG Cellular Biomedicine Group Inc [2020-08-14]
Novartis Pharma AG Gamida Cell Ltd [2018-11-08]
Novartis Pharma AG Cellular Biomedicine Group Inc [2018-09-28]
Novartis Pharma AG Akcea Therapeutics Inc [2017-07-27]
Novartis Pharma AG BioLineRx Ltd [2014-12-22]
Form 3/4/5 Subject 2011 - 2025
Novartis Pharma AG
Precision Biosciences Inc
Novartis AG
Cellular Biomedicine Group, Inc.
Poseida Therapeutics, Inc.
Idenix Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Terms | Privacy | Guide
tony@aum13f.com